These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9324850)

  • 1. [Experience with the use of immunochemotherapy in stage-IV colorectal cancer].
    Grinev MV; Abdusamatov FKh; Pivovarova LP; Golubeva AV
    Vestn Khir Im I I Grek; 1997; 156(3):68-72. PubMed ID: 9324850
    [No Abstract]   [Full Text] [Related]  

  • 2. [The role of adoptive immunotherapy in the combined treatment of neglected forms of colorectal cancer (a preliminary report)].
    Grinev MV; Gromov MI; Masiianskaia TI; Pivovarova LP; Razumova NK; Tarelkina MN; Frolov GM; Tsibin IuN; Shirokov DM
    Vestn Khir Im I I Grek; 1995; 154(3):50-5. PubMed ID: 8743786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cytoreductive surgery in the treatment of stage IV colorectal cancer].
    Grinëv MV; Abdusamatov FKh
    Vestn Khir Im I I Grek; 1998; 157(6):29-33. PubMed ID: 10672658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunotherapy in radical surgery of colorectal carcinoma].
    Brivio F; Fumagalli L; Chiarelli M; Denova M; Bertolini A; Cetta M; Nespoli A
    Chir Ital; 2007; 59(5):635-40. PubMed ID: 18019635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapeutic strategies in colorectal cancer].
    Flieger D; Keller R; Fischbach W
    Dtsch Med Wochenschr; 2003 Sep; 128(37):1902-7. PubMed ID: 12970825
    [No Abstract]   [Full Text] [Related]  

  • 6. Pre-operative immunoprophylaxis with interleukin-2 may improve prognosis in radical surgery for colorectal cancer stage B-C.
    Brivio F; Fumagalli L; Lissoni P; Nardone A; Nespoli L; Fattori L; Denova M; Chiarelli M; Nespoli A
    Anticancer Res; 2006; 26(1B):599-603. PubMed ID: 16739327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cytoreductive surgery as an alternative to palliative operations in oncology (the model of treatment of stage IV colorectal cancer)].
    Grinev MV
    Vestn Khir Im I I Grek; 2002; 161(6):100-3. PubMed ID: 12638509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chemo- and immunotherapy of colorectal cancer].
    Klein HO
    Internist (Berl); 1991 Jun; 32(6):348-53. PubMed ID: 1880013
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison between intravenous and oral postoperative adjuvant immunochemotherapy in patients with stage III colorectal cancer.
    Ito I; Mukai M; Ninomiya H; Kishima K; Tsuchiya K; Tajima T; Nakamura M; Makuuchi H
    Oncol Rep; 2008 Dec; 20(6):1521-6. PubMed ID: 19020736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant treatment of colorectal cancer: response to the NIH Consensus Summary Statement.
    Sherer PB
    Md Med J; 1991 Sep; 40(9):811-4. PubMed ID: 1921660
    [No Abstract]   [Full Text] [Related]  

  • 11. Postoperative follow-up of patients with colorectal cancer: a combined evaluation of CT scan, colonoscopy and tumour markers.
    Ntinas A; Zambas N; Al Mogrambi S; Petras P; Chalvatzoulis E; Frangandreas G; Tsantilas D; Spiridis C; Gerasimidis T
    Tech Coloproctol; 2004 Nov; 8 Suppl 1():s190-2. PubMed ID: 15655619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An anticancer drug sensitivity test to determine the effectiveness of UFT as postoperative adjuvant chemotherapy for patients with stage III colorectal cancer.
    Isogai A; Nagaya M; Matsuoka H; Watanabe T; Tsukikawa S; Kubota S
    Surgery; 2007 Nov; 142(5):741-8. PubMed ID: 17981195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colorectal cancer in patients over 70 years of age: determinants of outcome.
    Basdanis G; Papadopoulos VN; Michalopoulos A; Fahantidis E; Apostolidis S; Berovalis P; Zatagias A; Karamanlis E
    Tech Coloproctol; 2004 Nov; 8 Suppl 1():s112-5. PubMed ID: 15655591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors predicting survival in surgical palliative resection of stage IV colorectal cancer.
    Scabini S; Rimini E; Romairone E; Scordamaglia R; Pertile D; Ferrando V
    Minerva Chir; 2009 Jun; 64(3):303-6. PubMed ID: 19536056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colorectal cancer metastatic to the brain: time trends in presentation and outcome.
    Nieder C; Pawinski A; Balteskard L
    Oncology; 2009; 76(5):369-74. PubMed ID: 19321946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on postoperative colorectal cancer surveillance.
    Schwartz RW; McKenzie S
    Curr Surg; 2005; 62(5):491-4. PubMed ID: 16125604
    [No Abstract]   [Full Text] [Related]  

  • 17. Multidisciplinary treatment of colorectal cancer in New Zealand: survival rates from 1997-2002.
    Keating J; Yong D; Cutler G; Johnston J
    N Z Med J; 2006 Sep; 119(1242):U2238. PubMed ID: 16998579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating transforming growth factor beta 1 as a predictor of liver metastasis after resection in colorectal cancer.
    Tsushima H; Ito N; Tamura S; Matsuda Y; Inada M; Yabuuchi I; Imai Y; Nagashima R; Misawa H; Takeda H; Matsuzawa Y; Kawata S
    Clin Cancer Res; 2001 May; 7(5):1258-62. PubMed ID: 11350892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potential role of TGFbeta1, TGFbeta2 and TGFbeta3 protein expression in colorectal carcinomas. Correlation with classic histopathologic factors and patient survival.
    Tsamandas AC; Kardamakis D; Ravazoula P; Zolota V; Salakou S; Tepetes K; Kalogeropoulou C; Tsota I; Kourelis T; Makatsoris T; Karavias D; Scopa CD; Bonikos DS; Kalofonos HP; Petsas T
    Strahlenther Onkol; 2004 Apr; 180(4):201-8. PubMed ID: 15057430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Adjuvant treatment of colorectal cancers].
    Ducreux M; Rougier P
    Gastroenterol Clin Biol; 1994; 18(8-9):719-25. PubMed ID: 7875440
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.